Morgan Stanley now sees Moderna shares spiking 26% from current levels, cites 65% chance of success for v..
This Professor Was One of the First Investors in Vaccine-Maker Moderna. He's Now Worth Nearly $1 Billion
The inside story of how the $10 billion biotech Moderna developed a potential coronavirus vaccine in record time